Skip to main content
Clinical Trials/DRKS00004711
DRKS00004711CompletedNot Applicable

Consequences of steroid therapy on the adaptive immune system

niversitätsklinikum FreiburgCentrum für Chronische Immundefizienz, CCI0 sites72 target enrollmentStarted: February 26, 2014Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
72

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
50 Years to 90 Years (—)
Sex
All

Inclusion Criteria

  • arm 1: adult RZA or PMR patient under or up to 2 months after steroid therapy
  • arm 2: adult patients with cataract before surgery under or up to 2 months after steroid therapy, matched for age and sex

Exclusion Criteria

  • - patients with existing immune defects as antibody deficiency or severe cytopenia
  • - further immune suppressive therapies apart from MTX, especially after Rituximab therapy
  • - previous or current chemotherapy
  • - further reumathic basic diseases
  • - malignoma, especially lymphoma
  • arm 2: in addition: steroid therapy und/or MTX therapy currently or in the previous 2 months

Investigators

Sponsor
niversitätsklinikum FreiburgCentrum für Chronische Immundefizienz, CCI

Similar Trials